Santersus AG Showcases Innovation in Brain Health at BRAIN Conference 2024
December 3, 2024 – Santersus AG presented its groundbreaking NucleoCapture technology at the prestigious BRAIN Conference 2024 in London. The event brought together global experts to advance neurovascular research and discuss cutting-edge developments in brain health. Elevated cfDNA levels are associated with brain injuries and disorders, making it a potential biomarker for diagnosing and monitoring …
Santersus AG Showcases Innovation in Brain Health at BRAIN Conference 2024 Read More »